Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Kosacz BarbaraDirector | Grant or award | A | — 28.0K sh | Apr 13, 2026 |
| 9 | Teng Song-YuanDirector, Chief Executive Officer (Asia) | Grant or award | A | — 600.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Warzala Richard SDirector | Grant or award | A | — 2,827 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Langan BrianSee Remarks | Grant or award | A | — 911 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Monahan Michael P.Chief Financial Officer | Tax withholding | F | $25K 26.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Driscoll RimmaExecutive Vice President | Grant or award | A | $1,038 26 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Esch KevinExecutive Vice President | Grant or award | A | $55.28 1 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Lagano RoxanneExecutive Vice President | Grant or award | A | $22K 551 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Creed GregDirector | Grant or award | A | $34K 787 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Laughter John EEVP & Chief of Operations | Option exercise | M | — 9,080 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Holmes Chad MEVP AND CHIEF CORP DEV OFFICER | Grant or award | A | — 1,579 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Laughter John EEVP & Chief of Operations | Option exercise | M | — 13.5K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Filson Sean AndrewDirector | Grant or award | A | — 100.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Gray James DChief Financial Officer | Grant or award | A | — 99.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Yellin Jonathan DEVP AND GENERAL COUNSEL | Grant or award | A | — 1,396 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Solomon Lance I.Chief Product Officer | Tax withholding | F | $3,414 10.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Mulroy BrianChief Financial Officer | Tax withholding | F | $47K 3,941 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Lewis SheriCSO and COO | Tax withholding | F | $23K 24.9K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Bolton JeffreyDirector | Grant or award | A | $37K 2,680 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Krause Allyson G.General Counsel | Tax withholding | F | $6,646 20.8K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 8 | O'Connor CaseyChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $185K 60.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 8 | Moat RossCHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $80K 1,703 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 7 | Howard Justyn RussellDirector, Executive Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 6 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $59K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Shetty Reshma P.Director, See remarks, 10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $384K 35.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Canton Barry10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Renninger RobertCHIEF FINANCIAL OFFICER | Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec | Open-market sale · 10b5-1 plan | SELL | $7,970 693 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 4 | Perducat CyrilSVP, Chief Technology Officer | Option exercise · 10b5-1 plan | M | — 581 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 3,093 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Pomel OlivierDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 42.4K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 38.1K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Erlinger Joseph M.President, McDonald's USA | Option exercise · 10b5-1 plan | M | — 2,626 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 2 | Yuan Eric S.Director, Chief Executive Officer | Grant or award | A | — 561.6K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 1 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Open-market sale · 10b5-1 plan | SELL | $39K 500 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 1 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $143K 1,200 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Nagendran SukumarDirector, President and Head of R&D | Option exercise · 10b5-1 plan | M | $33K 19.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Howard Justyn RussellDirector, Executive Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |